TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
Jiawen Qian(Fudan University), Yiwei Chu(Fudan University), Yuting Deng(Shanghai Jiao Tong University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Mingfang Lu(Fudan University), Yuedi Wang(Fudan University), Ronghua Liu(Shanghai Medical College of Fudan University), Chen Wang(Shanghai Medical College of Fudan University), Jiyang Wang(Shanghai Medical College of Fudan University), Jiao Yang(Chinese Academy of Sciences), Zhou Lu(Fudan University), Luman Wang(Peking University)
Cited by 137
Related Papers
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Lipid metabolism in inflammation-related diseases
|The Analyst|2018|183
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
|The Journal of Immunology|2011|132